KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Revenue: 2019-2024

Historic Revenue for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Dec 2024 value amounting to $227.0 million.

  • Ginkgo Bioworks Holdings' Revenue fell 56.39% to $38.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $180.6 million, marking a year-over-year decrease of 17.13%. This contributed to the annual value of $227.0 million for FY2024, which is 9.71% down from last year.
  • According to the latest figures from FY2024, Ginkgo Bioworks Holdings' Revenue is $227.0 million, which was down 9.71% from $251.5 million recorded in FY2023.
  • Ginkgo Bioworks Holdings' Revenue's 5-year high stood at $477.7 million during FY2022, with a 5-year trough of $76.7 million in FY2020.
  • For the 3-year period, Ginkgo Bioworks Holdings' Revenue averaged around $318.7 million, with its median value being $251.5 million (2023).
  • Its Revenue has fluctuated over the past 5 years, first soared by 309.40% in 2021, then crashed by 47.36% in 2023.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Revenue stood at $76.7 million in 2020, then soared by 309.40% to $313.8 million in 2021, then spiked by 52.21% to $477.7 million in 2022, then tumbled by 47.36% to $251.5 million in 2023, then declined by 9.71% to $227.0 million in 2024.